冠状动脉手术较药物洗脱支架提供更佳生存获益:基于Kaplan-Meier衍生个体患者数据的汇总Meta分析
该汇总Meta分析纳入8项比较冠状动脉旁路移植术(CABG)与药物洗脱支架(DES)经皮冠状动脉介入治疗(PCI)的随机临床试验,共4975例CABG患者和4992例PCI患者。结果显示CABG组生存获益具有统计学显著性:发生率比为1.21(95%CI 1.09-1.35,P<.01),风险比为1.24(95%CI 1.11-1.38,P=.0001)。作者认为CABG较DES PCI提供一致的生存获益。
要点
- CABG组发生率比为1.21(95%CI 1.09-1.35,P<.01),生存获益有统计学显著性。
- CABG组1年、5年、10年生存率分别为97.1%、90.3%、80.3%。
- PCI组1年、5年、10年生存率分别为97.0%、87.7%、76.4%。
核心结论
- 该Meta分析提示CABG较DES PCI提供一致的生存获益。
研究设计与样本
- 检索PubMed、Embase和Google Scholar,纳入比较CABG与DES PCI的随机临床试验。
- 共纳入8项随机临床试验,CABG组4975例,PCI组4992例。
- 终点为总死亡率。
- 采用两种统计方法:通用逆方差法汇总发生率比,以及基于Kaplan-Meier衍生个体患者数据的汇总Meta分析。
主要发现
- 通用逆方差法显示CABG组生存获益有统计学显著性:发生率比1.21(95%CI 1.09-1.35,P<.01)。
- CABG组1年、5年、10年Kaplan-Meier生存率分别为97.1%、90.3%、80.3%。
- PCI组1年、5年、10年Kaplan-Meier生存率分别为97.0%、87.7%、76.4%。
- 对数秩分析证实CABG组总死亡率获益有统计学显著性:风险比1.24(95%CI 1.11-1.38,P=.0001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We explored the current evidence on coronary disease treatment comparing the survival of 2 therapeutic strategies: coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with drug-eluting stent (DES). METHODS: PubMed, Embase, and Google Scholar were searched for randomized clinical trials comparing CABG versus PCI with DES. The end point was overall mortality. Two statistical approaches were used: the generic inverse variance method, which was used to pool the incident rate ratios, and the pooled meta-analysis of Kaplan-Meier-derived individual patient data. RESULTS: Eight randomized clinical trials comparing 4975 patients undergoing CABG and 4992 patients undergoing PCI were included in our meta-analysis. Generic inverse variance method showed a statistically significant survival benefit of the CABG group (incident rate ratio, 1.21; 95% confidence interval, 1.09-1.35; P < .01). The Kaplan-Meier estimates of survival at 1, 5, and 10 years of the CABG group were 97.1%, 90.3%, and 80.3%, respectively. The Kaplan-Meier estimates of survival at 1, 5, and 10 years of the PCI group were 97.0%, 87.7%, and 76.4%, respectively. The log-rank analysis confirmed a statistically significant benefit in term of overall mortality of the CABG group (hazard ratio, 1.24; 95% confidence interval, 1.11-1.38; P = .0001). CONCLUSIONS: The present meta-analysis suggests that CABG provides a consistent survival benefit over PCI with DES.
引用
- Urso S, Sadaba R, González-Martín JM, et al. Coronary surgery provides better survival than drug-eluting stent: A pooled meta-analysis of Kaplan-Meier-derived individual patient data. J Thorac Cardiovasc Surg. 2023. PMID: 37001801. doi:10.1016/j.jtcvs.2023.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。